Marco J Herold Selected Research

Proteins (Proteins, Gene)

4/2024	The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a novel model of Duchenne muscular dystrophy.
2/2024	Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
12/2023	Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40.
12/2022	Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
1/2022	Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis.
12/2020	BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damage.
10/2020	The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
1/2020	EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
1/2019	TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.
1/2019	BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco J Herold Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 09/2007
11	Lymphoma (Lymphomas) 12/2023 - 04/2002
10	Inflammation (Inflammations) 02/2024 - 01/2018
5	Melanoma (Melanoma, Malignant) 01/2019 - 02/2009
4	Neoplasm Metastasis (Metastasis) 02/2024 - 06/2013
4	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2013
3	Multiple Myeloma 01/2021 - 10/2016
3	Infections 01/2018 - 09/2009
2	Necrosis 01/2024 - 01/2017
2	Arthritis (Polyarthritis) 10/2023 - 01/2020
2	Carcinogenesis 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
2	Salmonella Infections (Salmonellosis) 12/2021 - 01/2020
2	Sepsis (Septicemia) 12/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 09/2012
1	Fibrosis (Cirrhosis) 04/2024
1	Skin Diseases (Skin Disease) 01/2024
1	Dermatitis 01/2024
1	Stuttering (Stammering) 12/2023
1	Alphavirus Infections 10/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	2 X-Linked Lymphoproliferative Syndrome 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Immune System Diseases (Immune Disorders) 12/2022
1	COVID-19 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022
1	Tuberculosis (Tuberculoses) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Anemia 12/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	Lymphadenopathy 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Thrombocytosis (Thrombocythemia) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Fever (Fevers) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Shock 01/2019

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2012
7	venetoclaxIBA 02/2024 - 01/2020
4	CytokinesIBA 01/2024 - 01/2019
4	CaspasesIBA 01/2020 - 04/2002
3	ChemokinesIBA 01/2024 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2010
3	Phosphotransferases (Kinase)IBA 01/2020 - 09/2007
3	S63845IBA 10/2018 - 10/2016
2	Caspase 8 (Caspase-8)IBA 01/2023 - 01/2022
2	AntigensIBA 01/2023 - 01/2013
2	Histones (Histone)IBA 01/2022 - 01/2021
2	Estrogen ReceptorsIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2015
2	LigandsIBA 01/2018 - 12/2016
2	InterferonsIBA 01/2017 - 06/2013
2	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 11/2016 - 10/2016
2	Bcl-2-Like Protein 11IBA 01/2016 - 09/2012
2	Small Interfering RNA (siRNA)IBA 09/2009 - 09/2009
1	Protein Isoforms (Isoforms)IBA 04/2024
1	DystrophinIBA 04/2024
1	sharpinIBA 01/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2024
1	ArrestinIBA 12/2023
1	Peptidyl-Prolyl Isomerase DIBA 12/2023
1	VaccinesIBA 10/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Caspase 2IBA 12/2021
1	Death Domain ReceptorsIBA 10/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CalciumIBA 12/2020
1	Peroxidase (Myeloperoxidase)IBA 12/2020
1	AntibodiesIBA 01/2020
1	Humanized Monoclonal AntibodiesIBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	Serine-Threonine Kinase 3IBA 01/2020
1	Cyclin-Dependent Kinase 4IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	palbociclibIBA 01/2020
1	Proteasome InhibitorsIBA 01/2019
1	Caspase 12IBA 01/2019
1	Caspase 1 (ICE Protease)IBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Natural Cytotoxicity Triggering Receptor 1IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Lapatinib (GW572016)FDA Link 08/2017
1	Trastuzumab (Herceptin)FDA Link 08/2017

Therapy/Procedure

24	Therapeutics 12/2023 - 09/2007
5	Drug Therapy (Chemotherapy) 02/2024 - 12/2010
3	Transplantation 01/2023 - 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2020
1	Immunotherapy 12/2020
1	Mammaplasty (Breast Reconstruction) 01/2020
1	Radiotherapy 01/2018